PMID- 25687434 OWN - NLM STAT- MEDLINE DCOM- 20160223 LR - 20181113 IS - 1535-3699 (Electronic) IS - 1535-3702 (Print) IS - 1535-3699 (Linking) VI - 240 IP - 11 DP - 2015 Nov TI - Featured Article: Hypoxia-inducible factor-1alpha dependent nuclear entry of factor inhibiting HIF-1. PG - 1446-51 LID - 10.1177/1535370215570821 [doi] AB - The regulation of hypoxia-inducible factor-1 (HIF-1) transcriptional activity in the nucleus is related to factor inhibiting HIF-1 (FIH-1). FIH-1 hydrolyzes asparagine at the C-terminal of HIF-1alpha, preventing the interaction between HIF-1alpha and its associated cofactors, and leading to suppressed activation of HIF-1. FIH-1 is a cytosolic protein and its entry to the nucleus has to be coordinated with HIF-1alpha. The present study was undertaken to examine the correlation between HIF-1alpha and FIH-1 in their nuclear entry. Human umbilical vein endothelial cells were treated with dimethyloxalylglycine at a final concentration of 100 microM for 4 h, resulting in an accumulation of HIF-1alpha and an increase of FIH-1 in the nucleus as determined by Western blot analysis. Pretreatment of the cells with copper (Cu) chelator tetraethylenepentamine at 50 microM in cultures for 24 h reduced both HIF-1alpha protein levels and the HIF-1alpha entry to the nucleus, along with decreased FIH-1 protein levels in the nucleus but no changes in the total FIH-1 protein levels in the cells. These effects were prevented by simultaneous addition of 50 microM CuSO4 with tetraethylenepentamine. Gene-silencing of HIF-1alpha significantly inhibited FIH-1 entry to the nucleus, but did not affect the total protein levels of FIH-1 in the cells. This work demonstrates that the nuclear entry of FIH-1 depends on HIF-1alpha. Cu deficiency caused a decrease of HIF-1alpha, leading to suppression of FIH-1 entry to the nucleus. CI - (c) 2015 by the Society for Experimental Biology and Medicine. FAU - Liang, Ke AU - Liang K AD - Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan 610041, China. FAU - Ding, Xue-Qin AU - Ding XQ AD - Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan 610041, China. FAU - Lin, Chen AU - Lin C AD - Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan 610041, China. FAU - Kang, Y James AU - Kang YJ AD - Regenerative Medicine Research Center, Sichuan University West China Hospital, Chengdu, Sichuan 610041, China yjkang01@louisville.edu. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20150216 PL - Switzerland TA - Exp Biol Med (Maywood) JT - Experimental biology and medicine (Maywood, N.J.) JID - 100973463 RN - 0 (Amino Acids, Dicarboxylic) RN - 0 (Chelating Agents) RN - 0 (Ethylenediamines) RN - 0 (HIF1A protein, human) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (RNA, Small Interfering) RN - 0 (Repressor Proteins) RN - 7006-34-0 (Asparagine) RN - 789U1901C5 (Copper) RN - EC 1.- (Mixed Function Oxygenases) RN - EC 1.14.11.- (HIF1AN protein, human) RN - LRX7AJ16DT (Copper Sulfate) RN - VVW38EB8YS (oxalylglycine) RN - YZD1C9KQ28 (tetraethylenepentamine) SB - IM MH - *Active Transport, Cell Nucleus MH - Amino Acids, Dicarboxylic/chemistry MH - Asparagine/chemistry MH - Cell Nucleus/metabolism MH - Chelating Agents/chemistry MH - Copper/chemistry MH - Copper Sulfate/chemistry MH - Cytoplasm/metabolism MH - Cytosol/metabolism MH - Ethylenediamines/chemistry MH - Gene Silencing MH - Human Umbilical Vein Endothelial Cells MH - Humans MH - Hydrolysis MH - Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism MH - Mixed Function Oxygenases/*metabolism MH - Protein Structure, Tertiary MH - RNA, Small Interfering/metabolism MH - Repressor Proteins/genetics/*metabolism MH - Transcription, Genetic PMC - PMC4935306 OTO - NOTNLM OT - Copper OT - FIH-1 OT - HIF-1 OT - gene silencing OT - nuclear entry OT - tetraethylenepentamine EDAT- 2015/02/18 06:00 MHDA- 2016/02/26 06:00 PMCR- 2016/05/01 CRDT- 2015/02/18 06:00 PHST- 2014/07/25 00:00 [received] PHST- 2014/12/18 00:00 [accepted] PHST- 2015/02/18 06:00 [entrez] PHST- 2015/02/18 06:00 [pubmed] PHST- 2016/02/26 06:00 [medline] PHST- 2016/05/01 00:00 [pmc-release] AID - 1535370215570821 [pii] AID - 10.1177_1535370215570821 [pii] AID - 10.1177/1535370215570821 [doi] PST - ppublish SO - Exp Biol Med (Maywood). 2015 Nov;240(11):1446-51. doi: 10.1177/1535370215570821. Epub 2015 Feb 16.